Key Details
Annual ROE
-151.70%Beta
-Events Calendar
Next earnings date:
N/ARecent quarterly earnings:
Nov 09, 2022Recent annual earnings:
Mar 09, 2021Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
July 05, 2022Analyst ratings
Recent major analysts updates
No data about analysts updates
Screeners with BBI included
No data
Market Data
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Brickell Biotech doesn't have historical dividend data
Profitability
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Efficiency
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cash Flow
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Institutional Ownership
Similar stocks
Boundless Bio Announces Pipeline and Leadership Updates
BBI
globenewswire.com12 December 2024
Company elects not to advance BBI-825 into Part 2 portion of STARMAP clinical trial Third ecDTx program advancing, with plans for development candidate nomination by mid-2025 Operating runway extended into 2027, through anticipated clinical readout for BBI-355 and key development milestones for third ecDTx program Klaus Wagner, M.D., Ph.D., Chief Medical Officer, and Neil Abdollahian, Chief Business Officer, stepping down; James L.
FAQ
- What is the primary business of Brickell Biotech?
- What is the ticker symbol for Brickell Biotech?
- Does Brickell Biotech pay dividends?
- What sector is Brickell Biotech in?
- What industry is Brickell Biotech in?
- What country is Brickell Biotech based in?
- When did Brickell Biotech go public?
- Is Brickell Biotech in the S&P 500?
- Is Brickell Biotech in the NASDAQ 100?
- Is Brickell Biotech in the Dow Jones?
- When was Brickell Biotech's last earnings report?
- When does Brickell Biotech report earnings?
What is the primary business of Brickell Biotech?
Brickell Biotech, Inc., a clinical-stage pharmaceutical company, focuses on identifying, developing, and commercializing various prescription therapeutics for the treatment of debilitating skin diseases in the United States. The company's lead product candidate is sofpironium bromide that is in phase 3 clinical trial to treat patients with primary axillary hyperhidrosis. It has a collaboration agreement with AnGes, Inc. for the development of a novel DNA vaccine candidate for COVID-19. The company was founded in 2009 and is headquartered in Boulder, Colorado.
What is the ticker symbol for Brickell Biotech?
The ticker symbol for Brickell Biotech is NASDAQ:BBI
Does Brickell Biotech pay dividends?
No, Brickell Biotech does not pay dividends
What sector is Brickell Biotech in?
Brickell Biotech is in the Healthcare sector
What industry is Brickell Biotech in?
Brickell Biotech is in the Biotechnology industry
What country is Brickell Biotech based in?
Brickell Biotech is headquartered in United States
When did Brickell Biotech go public?
Brickell Biotech's initial public offering (IPO) was on 10 March 1993
Is Brickell Biotech in the S&P 500?
No, Brickell Biotech is not included in the S&P 500 index
Is Brickell Biotech in the NASDAQ 100?
No, Brickell Biotech is not included in the NASDAQ 100 index
Is Brickell Biotech in the Dow Jones?
No, Brickell Biotech is not included in the Dow Jones index
When was Brickell Biotech's last earnings report?
Brickell Biotech's most recent earnings report was on 9 November 2022
When does Brickell Biotech report earnings?
The date for Brickell Biotech's next earnings report has not been announced yet